BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

NCT01815450 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

369

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: BLI1100
DRUG: BLI1100 - modified formulation
DRUG: Placebo

Sponsor

Braintree Laboratories